Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christine C Tomlinson"'
Autor:
Olga Aprelikova, Christine C Tomlinson, Mark Hoenerhoff, Julie A Hixon, Scott K Durum, Ting-Hu Qiu, Siping He, Sandra Burkett, Zi-Yao Liu, Steven M Swanson, Jeffrey E Green
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155262 (2016)
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is associated with a poor prognosis and for which no targeted therapies currently exist. In order to improve preclinical testing for TNBC that relies primarily on usi
Externí odkaz:
https://doaj.org/article/6cbcebf108f04e098e704c0eee495b7b
Publikováno v:
Journal of Virology. 82:6514-6523
Kaposi's sarcoma-associated herpesvirus (KSHV) is a member of the gammaherpesvirus family. KSHV is the etiologic agent of Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. The first open reading frame of the KSHV geno
Publikováno v:
Cancer Research. 66:3658-3666
Kaposi's sarcoma–associated herpesvirus (KSHV) is linked to three different human cancers: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. The Kaposi's sarcoma lesion expresses high levels of angiogenic factors an
Autor:
Stuart P. Krall, Blossom Damania, Joseph S. Pagano, Christine C. Tomlinson, Ling Wang, Naohiro Wakisaka, Scott M. DeWire
Publikováno v:
Cancer Research. 64:2774-2781
Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) has been linked to Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. In addition to endothelial cells and B lymphocytes, KSHV also has been shown to infect ep
Publikováno v:
Journal of Virology. 78:1918-1927
Kaposi's sarcoma-associated herpesvirus (KSHV) has been implicated in Kaposi's sarcoma, as well as in primary effusion lymphoma and multicentric Castleman's disease. The K1 protein of KSHV has been shown to induce cellular transformation and focus fo
Autor:
Helen Piwinica-Worms, Melinda G. Hollingshead, Christina N. Bennett, Jeffrey E. Green, James Shou, Aleksandra M. Michalowski, Lara R. Mittereder, Olga Aprelikova, Christine C. Tomlinson, Isabel Chu, Natasha J. Caplen, Dror Luger
Publikováno v:
Breast Cancer Research : BCR
Introduction Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is diagnosed in approximately 15% of all human breast cancer (BrCa) patients. Currently, no targeted therapies exist for this subtype of BrCa and prognos
Autor:
Jennifer Webster-Cyriaque, Shannon C. Kenney, Christine C. Tomlinson, Marielle E. Yohe, Yuling Li
The Epstein-Barr virus (EBV) immediate-early (IE) protein BRLF1 (R) is a transcription factor that induces the lytic form of EBV infection. R activates certain early viral promoters through a direct binding mechanism but induces transcription of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a955357fdb82e6b227b856b02e7e4953
Autor:
Gary E. Pickard, Lynn W. Enquist, Jessica D. Kaufman, Cynthia A. Smeraski, Bruce W. Banfield, Christine C. Tomlinson, Christine L. Wilcox, Patricia J. Sollars
Intravitreal injection of the attenuated strain of pseudorabies virus (PRV Bartha) results in transneuronal spread of virus to a restricted set of central nuclei in the rat and mouse. We examined the pattern of central infection in the golden hamster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316559ee4188e4561ee893d7e23bfc7c
https://europepmc.org/articles/PMC6758319/
https://europepmc.org/articles/PMC6758319/
Publikováno v:
Virus research. 53(2)
Canine herpesvirus (CHV) is an alpha-herpesvirus of limited pathogenicity in healthy adult dogs and infectivity of the virus appears to be largely limited to cells of canine origin. CHV's low virulence and species specificity make it an attractive ca
Autor:
Lara R. Mittereder, Natasha J. Caplen, Jeffrey E. Green, Aleksandra M. Michalowski, Christine C. Tomlinson, Christina N. Bennett
Publikováno v:
Molecular Cancer Therapeutics. 10:A198-A198
Basal-like triple negative breast cancer (BTNBC) is characterized by the absence of estrogen receptor, progesterone receptor, and Her2 expression, and represents an estimated 15% of all human breast cancers. This subtype is highly prevalent in Africa